Navigation Links
Hologic Announces Fourth Quarter Fiscal 2013 Operating Results
Date:11/11/2013

ssociated with acquisitions, including without limitation, the Company's ability to successfully integrate acquired businesses, the risks that the acquired businesses may not operate as effectively and efficiently as expected even if otherwise successfully integrated, the risks that acquisitions may involve unexpected costs or unexpected liabilities, including the risks and challenges associated with the Company's recent acquisition of Gen‐Probe and operations in China; the risks of conducting business internationally; the risk of adverse exchange rate fluctuations on the Company's international activities and businesses; manufacturing risks, including the Company's reliance on a single or limited source of supply for key components, and the need to comply with especially high standards for the manufacture of many of its products; the Company's ability to predict accurately the demand for its products, and products under development, and to develop strategies to address its markets successfully; the early stage of market development for certain of the Company's products; the Company's leverage risks, including the Company's obligation to meet payment obligations and financial covenants associated with its debt; risks related to the use and protection of intellectual property; expenses, uncertainties and potential liabilities relating to litigation, including, without limitation, commercial, intellectual property, employment and product liability litigation; technical innovations that could render products marketed or under development by the Company obsolete; and competition.

The risks included above are not exhaustive. Other factors that could adversely affect the company's business and prospects are described in the filings made by the Company with the SEC. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any chan
'/>"/>

SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Hologic, Inc. Enhances Physician Training With Virtual Reality Simulation
2. FDA Approves Aptima HPV 16 18/45 Genotype Assay for Use on Hologics Panther System
3. Hologic to Host Investor Presentation at RSNA 2013
4. Hologic to Mark Start of Breast Cancer Awareness Month with NASDAQ Opening Bell Ceremony
5. Hologic to Present at Two Upcoming Investor Conferences
6. Hologic Announces Third Quarter Fiscal 2013 Operating Results
7. Hologic Announces Completion of Term Loan B Repricing
8. FDA Clears Hologics Single Energy Femur Exam to Visualize Features Associated with Developing Atypical Femur Fractures on a DXA Platform
9. FDA APPROVES APTIMA HPV ASSAY FOR USE ON HOLOGICS PANTHER SYSTEM
10. Hologic Appoints Jack W. Cumming President and Chief Executive Officer
11. Commercial Release of 3D (Breast Tomosynthesis) Biopsy Option Strengthens Hologics Position as Provider of the Nations Most Comprehensive Portfolio of Interventional Breast Health Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... ST. PAUL, Minn. , March 6, 2015 /PRNewswire/ ... benefit manager serving more than 26 million members, today ... and Drug Administration,s (FDA) approval of the first biosimilar ... U.S. Food and Drug Administration (FDA) approval of Sandoz,s ... of all cancer patients, is a major milestone in ...
(Date:3/6/2015)... 2015  Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in ... cancer, today announced that James A. Joyce , ... corporate overview at the 27th Annual ROTH Conference on ... was previously scheduled to present at 5:30 pm Pacific ... held at The Ritz-Carlton Hotel in Laguna ...
(Date:3/6/2015)... , March 6, 2015  Par Pharmaceutical Companies, ... conference call on Friday, March 13, 2015 at ... operations for the fourth quarter and full year ... and currently makes certain financial information available to ... and Exchange Commission and will make certain other ...
Breaking Medicine Technology:Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 2Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 3Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2
... Conn., Oct. 6 The Hedgeye Risk Management Healthcare team, led ... Conference Call, "Aging of America: Demographics of Demand and Profits in ... long tail of demographics, why 1994-2002 was so good, and why ... device demand, and the outlook for hip, knee, and spine device ...
... Oct. 6 Roxane Laboratories, Inc. announced today ... (ANDA) for Losartan Potassium Tablets USP, 25mg, 50mg ... Hydrochlorothiazide Tablets, 50mg/12.5mg and 100mg/25mg by the U.S. ... for immediate shipment to wholesalers and pharmacies nationwide. ...
Cached Medicine Technology:Aging of America: Demographics of Demand and Profits in Healthcare 2Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets 2
(Date:3/6/2015)... (PRWEB) March 06, 2015 Ticket Down is ... Levi's® Stadium in Santa Clara, California. This state-of-the-art ... hosted a plethora of exciting events. , The “Kick the ... his popular summer tour to the west coast and Levi’s ... facility will take place on August 29 and fans of ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Follow ... as the pharmacokinetics of a drug refers to testing ... compound inside an organism. When toxicity studies are clubbed ... ADMET or ADME/Tox. Increasing focus on lowering costs and ... ADME-toxicology testing worldwide. The traditional drug development model uses ...
(Date:3/6/2015)... Parents need to start the discourse ... use disorders. School programs like DARE, or Drug Abuse ... or Narcotics Overdose Prevention and Education has already impacted ... News on Feb. 27th. As teens continue to ... drug prevention proponents are lobbying Florida to pass The ...
(Date:3/6/2015)... 06, 2015 Johnson & Johnson and ... on March 5, 2015 in Superior Court in the ... documents, a jury of 12 awarded Mrs. Perry $700,000 ... implanted with an Ethicon TVT Abbrevo plastic sling for ... three women also awarded $5 million in punitive damages. ...
(Date:3/6/2015)... Washington, DC (PRWEB) March 06, 2015 ... the nation’s only comprehensive source for key trends and ... specialty spend, medical injectables. Executives from Magellan Rx Management ... Pharmacy Trend Report: Discover Your Hidden Specialty Drug Spend,” ... Atlantic Information Services, Inc. , Specialty drug spend makes ...
Breaking Medicine News(10 mins):Health News:Cheap Luke Bryan Tickets at Levi's® Stadium in Santa Clara, CA: Ticket Down Slashes Ticket Prices on Luke Bryan Concert Tickets in Santa Clara at the New Levi's® Stadium 2Health News:Cheap Luke Bryan Tickets at Levi's® Stadium in Santa Clara, CA: Ticket Down Slashes Ticket Prices on Luke Bryan Concert Tickets in Santa Clara at the New Levi's® Stadium 3Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2
... is due to intensive care overuse or underuse , FRIDAY, ... United States are nearly five times more likely to spend ... in England, finds a new study, and U.S. patients over ... the ICU when they die. , That,s the conclusion of ...
... Length of labor and intensity vary among ethnic groups, ... Asian women experience less labor pain than other women, ... influenced by many different factors but are difficult to ... Pamela Flood, of the anesthesia department at Columbia University, ...
... Oct. 30 Qualsec (OTC Bulletin Board: QLSZ), which ... has signed an agreement with Seamless Corporation (OTC Bulletin ... part of the arrangement, VitaminSpice products will sell through ... retail offerings and other products will be co-marketed in ...
... Therap Services is hosting its 4th annual National ... 2010. Therap provides electronic documentation and communication ... developmental disabilities. Therap complies and helps providers comply ... , Provider Administrators are senior positions such ...
... With the rapidly increasing problem of cardiovascular (CVD) disease ... raise awareness of risk factors. The European Society of ... adopt an integrated approach to CVD management, through important ... more prevalent in India and China than in all ...
... says former star major league pitcher , FRIDAY, Oct. 30 ... hand. In less than a second, it curves and then ... curveball, when thrown correctly, is one of baseball,s most daunting ... so great have sworn that the ball seems to have ...
Cached Medicine News:Health News:Patients More Likely to Die While in ICU in U.S. Than in England 2Health News:Asians Seem to Suffer Less During Childbirth 2Health News:VitaminSpice Signs MOU With Seamless Corp. for Sale of VitaminSpice Product Line on the Seamless Websites 2Health News:VitaminSpice Signs MOU With Seamless Corp. for Sale of VitaminSpice Product Line on the Seamless Websites 3Health News:Therap Services to Host Conference on Electronic Documentation, Electronic Signatures and Electronic Health Records for the Developmental Disabilities Community 2Health News:ESC events in Asia tackle management of diabetes and cardiovascular disease 2Health News:ESC events in Asia tackle management of diabetes and cardiovascular disease 3Health News:Scientist Throws Curve Into Breaking-Ball Debate 2Health News:Scientist Throws Curve Into Breaking-Ball Debate 3
... Electronic Medical Office (EMO) truly built for ... the unique needs of your practice. The ... electronic record system (EMR, EHR, and EPR), ... a new level of efficiency and performance. ...
... This program module functions stand alone. ... of the ophthalmicsuite product. The ASC module ... used in ophthalmic surgical specialty. Cataract, cosmetic, ... module. The ASC forms are adapted to ...
... is the perfect solution to assist you in ... control of your practice through the creative use ... pencil. No more impatient clients waiting to see ... old patient records. No more illegible handwriting on ...
... patient care reports for cardiology and ... reporting and documentation tool, physicians can ... H&P, labs, medications, and procedural details. ... with an e-signature, and distributed at ...
Medicine Products: